{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:17:41Z","timestamp":1787847461802,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:p>\u201cPsychopharmacoteratophobia is the fear or avoidance of prescribing psychotropic medicine to a pregnant woman on a given indication in anticipation of fetal malformation.\u201d It is rooted in the tragedy associated with thalidomide use and is increasing due to the inability to predict accurately, strict legal provision of consumer protection, ethical and legal issues involved, and pitfalls in the available evidence of teratogenicity. In the Indian setting, the physicians face more challenges as the majority of the patients may ask them to decide, what is the best for their health. Most guidelines emphasize more on what not to do than what to do, and the locus of decision is left to the doctor and the patient. In this review, we have focused on relevant issues related to psychopharmacoteraophobia that may be helpful to understand this phenomenon and help to address the deprivation of a mentally ill woman from the required treatment.<\/jats:p>","DOI":"10.4103\/0253-7613.165186","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T06:44:00Z","timestamp":1442385840000},"page":"484-490","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Psychopharmacoteratophobia: Excessive fear of malformation associated with prescribing psychotropic drugs during pregnancy: An Indian perspective"],"prefix":"10.4103","volume":"47","author":[{"given":"Dushad","family":"Ram","sequence":"first","affiliation":[{"name":"Department of Psychiatry, JSS Medical College, JSS University, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavnna","family":"Gowdappa","sequence":"additional","affiliation":[{"name":"Department of Medicine, JSS Medical College, JSS University, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G.","family":"Ashoka","sequence":"additional","affiliation":[{"name":"Department of Medicine, JSS Medical College, JSS University, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"Eiman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, JSS Medical College, JSS University, Mysore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20260528","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: The tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"key":"R4-20260528","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0890-6238(01)00185-X","article-title":"Is this drug safe in pregnancy?","volume":"15","author":"Webster","year":"2001","journal-title":"Reprod Toxicol"},{"key":"R5-20260528","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reprotox.2006.11.005","article-title":"The effectiveness of Teratology Information Services (TIS)","volume":"23","author":"Hancock","year":"2007","journal-title":"Reprod Toxicol"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00315304","article-title":"Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP)","volume":"45","author":"Marchetti","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"R7-20260528","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.genhosppsych.2012.09.003","article-title":"Benzodiazepine exposure in pregnancy and risk of major malformations: A critical overview","volume":"35","author":"Bellantuono","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"R8-20260528","first-page":"3","article-title":"The safety of psychotropic drug use during pregnancy: A review","volume":"7","author":"Einarson","year":"2005","journal-title":"MedGenMed"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2012.01.005","article-title":"Valproate and the risk for congenital malformations: Is formulation and dosage regime important?","volume":"21","author":"Mawhinney","year":"2012","journal-title":"Seizure"},{"key":"R10-20260528","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK epilepsy and pregnancy register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-20260528","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000227919.81208.b2","article-title":"In utero antiepileptic drug exposure: Fetal death and malformations","volume":"67","author":"Meador","year":"2006","journal-title":"Neurology"},{"key":"R12-20260528","first-page":"259","article-title":"Methodological issues in setting up a surveillance system for birth defects in India","volume":"18","author":"Suresh","year":"2005","journal-title":"Natl Med J India"},{"key":"R13-20260528","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0971-6866.73412","article-title":"Congenital malformations at birth in Central India: A rural medical college hospital based data","volume":"16","author":"Taksande","year":"2010","journal-title":"Indian J Hum Genet"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02834415","article-title":"East-West differentials in congenital malformations in India","volume":"49","author":"Chinara","year":"1982","journal-title":"Indian J Pediatr"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5005\/jp-journals-10009-1345","article-title":"Psychotropic medication use during pregnancy and lactation: Role of ultrasound assessment","volume":"8","author":"Matthys","year":"2014","journal-title":"Donald Sch J Ultrasound Obstet Gynecol"},{"key":"R16-20260528","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1176\/ajp.156.6.955","article-title":"Chart-recorded psychiatric diagnoses in women giving birth in California in 1992","volume":"156","author":"Kelly","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0163-8343(01)00129-3","article-title":"Somatic complaints among pregnant women cared for in obstetrics: Normal pregnancy or depressive and anxiety symptom amplification revisited?","volume":"23","author":"Kelly","year":"2001","journal-title":"Gen Hosp Psychiatry"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mob.2003.336","article-title":"Point prevalence of psychiatric disorders during the second trimester of pregnancy: A population-based study","volume":"189","author":"Andersson","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.65.7.805","article-title":"Psychiatric disorders in pregnant and postpartum women in the United States","volume":"65","author":"Vesga-L\u00f3pez","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R20-20260528","first-page":"44","article-title":"Abrupt discontinuation of psychotropic drugs during pregnancy: Fear of teratogenic risk and impact of counselling","volume":"26","author":"Einarson","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"R21-20260528","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1701-2163(15)30905-1","article-title":"Barriers to the pharmacological treatment of women with psychiatric disorders during pregnancy and breastfeeding: Results of a survey","volume":"35","author":"Einarson","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"R22-20260528","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7150\/ijms.2.100","article-title":"Risk and benefit of drug use during pregnancy","volume":"2","author":"B\u00e1nhidy","year":"2005","journal-title":"Int J Med Sci"},{"key":"R33-20260528","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.20540","article-title":"National Birth Defects Prevention Study. Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study","volume":"85","author":"Collier","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R34-20260528","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/bdra.20195","article-title":"Maternal influenza during pregnancy and risk of congenital abnormalities in offspring","volume":"73","author":"Acs","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R35-20260528","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1741-4520.2006.00108.x","article-title":"Acute respiratory infections during pregnancy and congenital abnormalities: A population-based case-control study","volume":"46","author":"Acs","year":"2006","journal-title":"Congenit Anom (Kyoto)"},{"key":"R37-20260528","first-page":"15","article-title":"Safety in the evaluation of potentially violent patients","volume":"27","author":"Dubin","year":"2010","journal-title":"Psychiatr Times"},{"key":"R38-20260528","first-page":"12","article-title":"Atypical antipsychotics during Pregnancy: Make decisions based on available evidence, individualized risk\/benefit analysis","volume":"12","author":"Robakis","year":"2013","journal-title":"Curr Psychiatry"},{"key":"R41-20260528","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/bdra.20139","article-title":"Causation in teratology-related litigation","volume":"73","author":"Scialli","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R42-20260528","first-page":"295","article-title":"The environment and disease: Association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"R45-20260528","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S1701-2163(16)32668-8","article-title":"Principles of human teratology: Drug, chemical, and infectious exposure","volume":"29","author":"Wilson","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"R46-20260528","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/humupd\/dmp052","article-title":"Teratogenic mechanisms of medical drugs","volume":"16","author":"van Gelder","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R50-20260528","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archpsyc.1997.01830130055011","article-title":"Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment","volume":"54","author":"Viguera","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"R51-20260528","first-page":"14","article-title":"Strategies for Discontinuing psychotropic medications","volume":"4","author":"Hoga","year":"2014","journal-title":"Can Geriatr Soc J CME"},{"key":"R54-20260528","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrn1986","article-title":"Neural tube defects and folate: Case far from closed","volume":"7","author":"Blom","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"R55-20260528","first-page":"750485","article-title":"Extrinsic factors influencing fetal deformations and intrauterine growth restriction","author":"Moh","year":"2012","journal-title":"J Pregnancy 2012"},{"key":"R56-20260528","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000360602","article-title":"European recommendations for primary prevention of congenital anomalies: A joined effort of EUROCAT and EUROPLAN projects to facilitate inclusion of this topic in the National Rare Disease Plans","volume":"17","author":"Taruscio","year":"2014","journal-title":"Public Health Genomics"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363791-201547050-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:18:58Z","timestamp":1787843938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363791-201547050-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0253-7613.165186","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"2015-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}